GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

SP-0230 is under clinical development by Sanofi and currently in Phase II for Neisseria meningitidis Infections.

For animals, 2024 was full of milestones that stopped suffering and saved lives. More people have realized that every animal is someone with a right to be treated with kindness and respect.

Researchers design a new way to more reliably evaluate AI models' ability to make clinical decisions in realistic scenarios that closely mimic real-life interactions. The analysis finds that ...

A Florida-based car dealer has joined mounting litigation against Eli Lilly, Novo Nordisk and Sanofi over what it calls the ...

Share prices of Aurora Innovation dropped for a fourth consecutive day on Thursday as investors continued to sell off ...

In separate DLL3 antibody-drug conjugate (ADC) deals, Roche licensed from Innovent Biologics and Ideaya reached for Hengrui.

In 2023, drug companies launched new medications at prices 35 percent higher than the year before. On January 1, Pfizer ...

Drugmakers plan to raise US prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol ...

Researchers developed AbMAP, a cutting-edge framework leveraging transfer learning to model antibody hypervariable regions, ...

By adapting artificial intelligence models known as large language models, researchers have made great progress in their ...

Pharmaceutical companies raised the list prices of at least 250 prescriptions heading into 2025 as major changes to the ...